Ivermectin Attenuates CCl(4)-Induced Liver Fibrosis in Mice by Suppressing Hepatic Stellate Cell Activation

Liver fibrosis, a common liver dysfunction with high morbidity and mortality rates, is the leading cause of cirrhosis and hepatocellular carcinoma, for which there are no effective therapies. Ivermectin is an antiparasitic drug that also has been showing therapeutic actions in many other diseases, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Hanglu, Li, Long, Zhao, Yufen, Ni, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782196/
https://www.ncbi.nlm.nih.gov/pubmed/36555680
http://dx.doi.org/10.3390/ijms232416043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9782196/
https://www.ncbi.nlm.nih.gov/pubmed/36555680
http://dx.doi.org/10.3390/ijms232416043

Ejemplares similares